Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 20;9(2):209.
doi: 10.3390/microorganisms9020209.

Multicenter Evaluation of an ELISA for the Detection of Cryptosporidium spp. Antigen in Clinical Human Stool Samples

Collaborators, Affiliations

Multicenter Evaluation of an ELISA for the Detection of Cryptosporidium spp. Antigen in Clinical Human Stool Samples

Romy Razakandrainibe et al. Microorganisms. .

Abstract

Human cryptosporidiosis remains underdiagnosed, and rapid/accurate diagnosis is of clinical importance. Diagnosis of the Cryptosporidium oocyst in stool samples by conventional microscopy is labor-intensive, time-consuming, and requires skillful experience. Thus, we aimed to evaluate the usefulness of a coproantigen enzyme-linked immunosorbent assay (ELISA) test in detecting Cryptosporidium spp. from fecal specimens. For this aim, we evaluated the performances of a commercial ELISA (CoproELISA Cryptosporidium kit, Savyon Diagnostics, Israel) for the detection of Cryptosporidium spp. in random clinical stool samples through a multicenter study. The sensitivity and specificity for coproantigen ELISA were 98.86% and 94.32%, respectively. The coproantigen ELISA results indicate that the simple, rapid, reliable, and standardized immunoassay test is sensitive and specific for routine diagnosis, and may be useful for large-scale epidemiological studies of cryptosporidiosis.

Keywords: Cryptosporidium spp.; coproantigen ELISA; cryptosporidiosis; diagnosis; large-scale epidemiology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Ryan U., Fayer R., Xiao L. Cryptosporidium Species in Humans and Animals: Current Understanding and Research Needs. Parasitology. 2014;141:1667–1685. doi: 10.1017/S0031182014001085. - DOI - PubMed
    1. Dillingham R.A., Lima A.A., Guerrant R.L. Cryptosporidiosis: Epidemiology and Impact. Microbes Infect. 2002;4:1059–1066. doi: 10.1016/S1286-4579(02)01630-1. - DOI - PubMed
    1. Khurana S., Chaudhary P. Laboratory Diagnosis of Cryptosporidiosis. Trop. Parasitol. 2018;8:2. doi: 10.4103/tp.TP_34_17. - DOI - PMC - PubMed
    1. Vanathy K., Parija S.C., Mandal J., Hamide A., Krishnamurthy S. Detection of Cryptosporidium in Stool Samples of Immunocompromised Patients. Trop. Parasitol. 2017;7:41–46. doi: 10.4103/tp.TP_66_16. - DOI - PMC - PubMed
    1. Garcia L.S., Shimizu R.Y., Bernard C.N. Detection of Giardia Lamblia, Entamoeba Histolytica/Entamoeba Dispar, and Cryptosporidium Parvum Antigens in Human Fecal Specimens Using the Triage Parasite Panel Enzyme Immunoassay. J. Clin. Microbiol. 2000;38:3337–3340. doi: 10.1128/JCM.38.9.3337-3340.2000. - DOI - PMC - PubMed

LinkOut - more resources